Dr Helena Andres Terre, Dr Nikola Simidjievski and Dr Zohreh Shams talk about integrative and interpretable artificial intelligence (AI) tools for bench to bedside research in cancer medicine. They highlight their project to build an AI platform to integrate multiple data modalities, initially with retrospective data, but eventually with the aim of using prospective data from cancer patients in real time thereby tailoring treatment for patients. They work in collaboration with the CRUK Cambridge Centre’s Breast Cancer Programme as well as with experts from within the data streams: genomics, imaging, and digital pathology.
Helena, Nikola and Zohreh are all Research Associates from the Department of Computer Science and Technology at the University of Cambridge, UK. All three are both members of and are funded by the Mark Foundation Institute for Integrated Cancer Medicine.
